Interestingly, concomitant blockade of CD39 and CD73 in T cells from healthy donors and breast cancer patients displayed a potent reversal of adenosine-mediated T cell inhibition and augmented anti-tumor response 115. This evidence concerns the gene NT5E and neoplasm.